Showing results (231-240 of 263) with videos related to

Sort By:
Pageof 27
Head & Neck|February 6, 2016
Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low-risk patient as defined by targeted sequencingBrittny N Tillman, Megan Yanik, Andrew C Birkeland, et al.
Head & Neck|December 14, 2011
UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell lineAlice L Tang, Samantha J Hauff, John H Owen, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosisMatthew H Stenmark, Jonathan B McHugh, Matthew Schipper, et al.
Human Pathology|June 17, 2020
A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutationsTimothy I Miller, Nicholas A Zoumberos, Bryan Johnson, et al.
The American Journal of Surgical Pathology|January 21, 2015
Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenomaAaron M Udager, Jincheng Pan, Martin J Magers, et al.
BMC Cancer|November 1, 2015
NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomasShama Virani, Emily Bellile, Carol R Bradford, et al.
Oral Oncology|April 26, 2017
Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinomaAndrew C Birkeland, Susan K Foltin, Nicole L Michmerhuizen, et al.
Head & Neck|January 17, 2012
Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR statusMatthew E Spector, K Kelly Gallagher, Emily Light, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 20, 2016
Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma TreatmentMatthew E Spector, Steven B Chinn, Emily Bellile, et al.
The Journal of Pathology|May 29, 2016
Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinomaAaron M Udager, Jonathan B McHugh, Bryan L Betz, et al.
Pageof 27